Influence of Hospital Procedural Volume on Care Process and Mortality for Patients Undergoing Elective Surgery for Mitral Regurgitation

Background— Few studies have examined the procedural volume–outcome relationship for heart valve surgery. None have examined process of care factors that may be mediators of this association. Methods and Results— This was a retrospective review of outcomes for 13 614 patients having elective surgery for mitral regurgitation between 2000 and 2003 in 575 North American centers participating in the Society of Thoracic Surgeons National Cardiac Database. Hospital annual mitral valve volume varied widely from 22 cases per year in the lowest-volume quartile to 394 in the highest. Unadjusted mortality rates decreased from 3.08% in the lowest-volume category to 1.11% in the highest-volume category. The risk-adjusted odds ratio for mortality in the highest-volume category compared with the lowest was 0.48 (95% confidence interval 0.28 to 0.82). The rates of mitral valve repair increased from 47.7% in the lowest-volume quartile to 77.4% in high-volume hospitals (P<0.0001). Similarly, the rates of bioprosthetic valve use for patients aged >65 years rose from 59% in the lowest-volume quartile to 75% in the highest-volume quartile (P=0.0002). The association between volume and mortality was still significant but attenuated when the risk adjustment was modified to adjust for mitral valve repair versus replacement. Conclusions— Hospital procedural volume was associated with higher frequency of valve repair, higher frequency of prosthetic valve usage in elderly patients, and lower adjusted operative mortality. Differences in care process may contribute to improved outcomes in higher-volume centers.

[1]  E. Oger,et al.  Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study. , 2007, Thrombosis research.

[2]  R. Vieth.  What is the optimal vitamin D status for health? , 2006, Progress in biophysics and molecular biology.

[3]  A. Lahiri,et al.  The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. , 2006, Journal of the American College of Cardiology.

[4]  R. Bonow,et al.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.

[5]  J. Sulkes,et al.  Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality. , 2006, Atherosclerosis.

[6]  K. Lunetta,et al.  Estrogen Receptor (cid:1) Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts , 2006 .

[7]  K. Korach,et al.  Estrogen receptors and human disease. , 2006, The Journal of clinical investigation.

[8]  W. Burchert,et al.  Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  D. Kelly,et al.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.

[10]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[11]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[12]  R. Langer,et al.  Mitral and Aortic Annular Calcification Are Highly Associated With Systemic Calcified Atherosclerosis , 2006, Circulation.

[13]  I. Thompson,et al.  Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. , 2006, The Journal of urology.

[14]  V. Chan,et al.  Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. , 2003, The Journal of thoracic and cardiovascular surgery.

[15]  HiroyasuIso,et al.  Dietary Intake of Calcium in Relation to Mortality From Cardiovascular Disease , 2006 .

[16]  W. Jamieson,et al.  Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. , 2006, The Journal of thoracic and cardiovascular surgery.

[17]  Christophe Leclercq,et al.  Cardiac resynchronization therapy: Part 1--issues before device implantation. , 2005, Journal of the American College of Cardiology.

[18]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[19]  S. Cummings,et al.  Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian women , 2005 .

[20]  D. Housman,et al.  Estrogen Receptor α Gene Variation and the Risk of Stroke , 2005 .

[21]  M. Barbagallo,et al.  Bisphosphonates and atherosclerosis: why? , 2005, Lupus.

[22]  M. Aubry,et al.  Genetic variation at the estrogen receptor α locus in relation to venous thromboembolism risk among postmenopausal women , 2005, Journal of thrombosis and haemostasis : JTH.

[23]  G. Bluhm,et al.  Daily Intake of Magnesium and Calcium From Drinking Water in Relation to Myocardial Infarction , 2005, Epidemiology.

[24]  E. Schelbert,et al.  Hospital Volume and Selection of Valve Type in Older Patients Undergoing Aortic Valve Replacement Surgery in the United States , 2005, Circulation.

[25]  B. Hua,et al.  [The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer]. , 2005, Zhonghua wai ke za zhi [Chinese journal of surgery].

[26]  R. Nuti,et al.  Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. , 2005, American journal of epidemiology.

[27]  A. Hoeft,et al.  Unfavorable effects of ventricular pacing on myocardial energetics , 1981, Basic Research in Cardiology.

[28]  D. Grobbee,et al.  The estrogen receptor alpha gene and breast cancer risk (The Netherlands). , 2005, Cancer causes & control : CCC.

[29]  P. Reaven,et al.  Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes , 2005, Diabetologia.

[30]  A. Uitterlinden,et al.  Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. , 2004, JAMA.

[31]  R. Evans,et al.  Regulation of Muscle Fiber Type and Running Endurance by PPARδ , 2004, PLoS biology.

[32]  T. Araki,et al.  Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. , 2004, Anticancer research.

[33]  Michael Pignone,et al.  Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. , 2004, Archives of internal medicine.

[34]  D. Towler,et al.  Osteogenic regulation of vascular calcification: an early perspective. , 2004, American journal of physiology. Endocrinology and metabolism.

[35]  A. Diedrich,et al.  Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Mice Through Parasympathetic Activation , 2004, Hypertension.

[36]  Jeroen J. Bax,et al.  The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. , 2004, Journal of the American College of Cardiology.

[37]  Robert E Harbaugh,et al.  Surgeon Volume and Operative Mortality in the United States. , 2004, Neurosurgery.

[38]  C. Acar,et al.  Contemporary results of mitral valve repair for infective endocarditis. , 2004, Journal of the American College of Cardiology.

[39]  Ju Han Kim,et al.  Estrogen Receptor Alpha Gene Polymorphisms and Breast Cancer Risk , 2003, Breast Cancer Research and Treatment.

[40]  A. Hofman,et al.  Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. , 2004, JAMA.

[41]  N. Chen,et al.  Vascular calcification in chronic kidney disease. , 2004, Seminars in nephrology.

[42]  J. Birkmeyer,et al.  Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? , 2003, The Annals of thoracic surgery.

[43]  A. LaCroix,et al.  The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. , 2003, Annals of epidemiology.

[44]  Kazuto Ito,et al.  Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol‐O‐methyltransferase are associated with familial prostate carcinoma risk in a Japanese population , 2003, Cancer.

[45]  Scott Davis,et al.  Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.

[46]  C. Kooperberg,et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.

[47]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Douchi,et al.  Association of Estrogen Receptor α and β3‐Adrenergic Receptor Polymorphisms With Endometrial Cancer , 2003 .

[49]  X. Shu,et al.  Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  R. Dahiya,et al.  Polymorphisms of estrogen receptor alpha in prostate cancer , 2003, Molecular carcinogenesis.

[51]  Jiandie D. Lin,et al.  Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells* , 2003, Journal of Biological Chemistry.

[52]  E. Savage,et al.  Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. , 2003, The Annals of thoracic surgery.

[53]  S. Normand,et al.  The volume-outcome relationship: from Luft to Leapfrog. , 2003, The Annals of thoracic surgery.

[54]  E. Fallen,et al.  Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative Metabolism , 2003, Circulation.

[55]  D. Levy,et al.  Chorioamnionitis and cerebral palsy in term and near-term infants , 2004 .

[56]  Xiping Xu,et al.  [Association of estrogen receptor gene polymorphism with cerebral infarction, a case-control study]. , 2002, Zhonghua yi xue za zhi.

[57]  Ethan A Halm,et al.  Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature , 2002, Annals of Internal Medicine.

[58]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[59]  Christopher M. Tan,et al.  Heterozygous α2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Bleecker,et al.  Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. , 2002, The New England journal of medicine.

[61]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[62]  N. Scherbaum,et al.  Sympathetic Neural Activation Evoked by &mgr;-Receptor Blockade in Patients Addicted to Opioids Is Abolished by Intravenous Clonidine , 2002, Anesthesiology.

[63]  J. Stuart,et al.  Superoxide activates mitochondrial uncoupling proteins , 2002, Nature.

[64]  H. Mabuchi,et al.  Association of Estrogen Receptor-Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia , 2002 .

[65]  Markus Perola,et al.  Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study , 2002, Journal of Molecular Medicine.

[66]  C H Chen,et al.  Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. , 2001, Journal of the American College of Cardiology.

[67]  J. Cauley,et al.  Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  A. Berrebi,et al.  Long-Term (29 Years) Results of Reconstructive Surgery in Rheumatic Mitral Valve Insufficiency , 2001, Circulation.

[69]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[70]  Gregory S. Nelson,et al.  Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.

[71]  B. Astor,et al.  Mortality after aortic valve replacement: results from a nationally representative database. , 2000, The Annals of thoracic surgery.

[72]  A L Shroyer,et al.  The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. , 2000, The Annals of thoracic surgery.

[73]  H. Melhus,et al.  Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. , 2000, Carcinogenesis.

[74]  E. Fallen,et al.  The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study. , 2000, Circulation.

[75]  T. Sellers,et al.  Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. , 1999, American journal of epidemiology.

[76]  E. Antman,et al.  Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[77]  G M Lawrie,et al.  Mitral valve repair vs replacement. Current recommendations and long-term results. , 1998, Cardiology clinics.

[78]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[79]  T. Zama,et al.  Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[80]  M. Yokoyama,et al.  Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. , 1996, Circulation.

[81]  P. Grayburn,et al.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.

[82]  P. Grayburn,et al.  Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. , 1994, Journal of the American College of Cardiology.

[83]  A. Buck,et al.  An approach to ventricular efficiency by use of carbon 11-labeled acetate and positron emission tomography , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[84]  K. Svärdsudd,et al.  Cardiovascular mortality and morbidity in seven counties in Sweden in relation to water hardness and geological settings. The project: myocardial infarction in mid-Sweden. , 1992, European heart journal.

[85]  M. Dontenwill,et al.  Imidazoline receptors. A new concept in central regulation of the arterial blood pressure. , 1992, American journal of hypertension.

[86]  M. Schwaiger,et al.  Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. , 1992, American heart journal.

[87]  J. Dekker,et al.  Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. , 1992, International journal of epidemiology.

[88]  F. Eberli,et al.  Myocardial oxygen consumption in aortic valve disease with and without left ventricular dysfunction. , 1992, British heart journal.

[89]  W D Dupont,et al.  Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. , 1992, Cancer research.

[90]  C. Mathias,et al.  Hemodynamic and Neurohormonal Effects of Clonidine in Patients With Preganglionic and Postganglionic Sympathetic Lesions: Evidence for a Central Sympatholytic Action , 1991, Circulation.

[91]  F. Kummerow.  Nutrition imbalance and angiotoxins as dietary risk factors in coronary heart disease. , 1979, The American journal of clinical nutrition.

[92]  A. Malik,et al.  Cardiac function, coronary flow, and oxygen consumption in stable left ventricular hypertrophy. , 1973, The American journal of physiology.

[93]  A. Schwartz,et al.  Antihypertensive Effect of Clonidine , 1971, Circulation research.